This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Dec 6;345(23):1711-2.

doi: 10.1056/NEJM200112063452317.

Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma

A J Pantuck, A S Belldegrun, R A Figlin

PMID: 11759660
DOI: 10.1056/NEJM200112063452317

Comment

Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma

A J Pantuck et al. N Engl J Med. 2001.

. 2001 Dec 6;345(23):1711-2.

doi: 10.1056/NEJM200112063452317.

Authors

A J Pantuck, A S Belldegrun, R A Figlin

PMID: 11759660
DOI: 10.1056/NEJM200112063452317

No abstract available

PubMed Disclaimer

Comment in

Removing the primary tumor after the cancer has spread.
Tannock IF. Tannock IF. N Engl J Med. 2001 Dec 6;345(23):1699-700. doi: 10.1056/NEJM200112063452310. N Engl J Med. 2001. PMID: 11759650 No abstract available.

Comment on

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR Jr, Munshi N, Crawford ED. Flanigan RC, et al. N Engl J Med. 2001 Dec 6;345(23):1655-9. doi: 10.1056/NEJMoa003013. N Engl J Med. 2001. PMID: 11759643 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information